Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Will Hydroxychloroquine Impede or Prevent COVID-19: WHIP COVID-19 Study

NCT04341441 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04341441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Will Hydroxychloroquine Impede or Prevent COVID-19: WHIP COVID-19 Study
Lead sponsor
Henry Ford Health System
Phase
Phase 3
Overall status
Terminated
Start date
April 7, 2020
Completion date
December 15, 2020
Enrollment
624 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, coronavirus infections, covid-19, sars-cov 2